Nutrend BCAA 4:1:1 100 tablets
Essential branched-chain amino acids L-leucine, L-isoleucine and L-valine (BCAA) in the form of tablets. The tablets are a precise and convenient form of dosing, and each tablet contains 1.5 g of BCAA. The essential branched-chain amino acids are present in this product in a ratio of 4:1:1 for L-leucine. During demanding physical activity, individual amino acids are depleted along with other important substances. Amino acids are the building blocks of every protein. A sufficient intake of quality protein with an optimal amino acid profile contributes to muscle growth. Branched-chain amino acids are among the essential ones that the body must take in through food, because it does not synthesise them from other sources.
- amino acid ratio 4:1:1 for L-leucine
- high BCAA content – 1500 mg in one tablet
- higher proportion of L-leucine
- practical dosing in tablet form
Recommended dosage: dose according to body weight. Up to 90 kg body weight 6 tablets a day, 90 - 120 kg 8 tablets a day, over 120 kg 10 tablets a day. To improve performance, take half of the daily dose 45 - 60 minutes before exercise. For maximum support, take the second half of the dose immediately after training. Do not exceed the recommended dosage.
Ingredients
L-leucine, L-isoleucine, L-valine, bulking agent microcrystalline cellulose, anti-caking agents magnesium stearate and silicon dioxide.
Nutritional information
| 6 tablets | 8 tablets | 10 tablets | |
|---|---|---|---|
| L-Leucine | 6 000 mg | 8 000 mg | 10 000 mg |
| L-Isoleucine | 1 500 mg | 2 000 mg | 2 500 mg |
| L-Valine | 1 500 mg | 2 000 mg | 2 500 mg |
| 1 tablet: 2 000 mg | |||
| Net weight of the contents: 200 g (100 tablets) | |||
| Net weight of the contents: 600 g (300 tablets) |
| EAN: | 8594073176370 |
| model year: | nespecifikován |















































































































































































































































































































































































































































































